methylene blue has been researched along with Diabetic Neuropathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kulkarni, SK; Patil, CS; Singh, S; Singh, VP | 1 |
Byers, PD; Page, KM | 1 |
2 other study(ies) available for methylene blue and Diabetic Neuropathies
Article | Year |
---|---|
Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Pain Threshold; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones | 2004 |
Axonic swellings demonstrated by a supravital methylene blue technique.
Topics: Aged; Amputation, Surgical; Amyotrophic Lateral Sclerosis; Anemia, Hypochromic; Axons; Bone Neoplasms; Chondrosarcoma; Diabetic Neuropathies; Edema; Glycosuria; Humans; Hyperglycemia; Injections, Intramuscular; Leg; Male; Methods; Methylene Blue; Motor Neurons; Muscles; Muscular Diseases; Neuritis; Neuromuscular Junction; Porphyrias; Staining and Labeling; Vitamin B Deficiency | 1969 |